- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Gall Bladder Carcinoma in United States
Total 170056 results
-
University of UtahExelixisActive, not recruitingBladder Cancer | Metastatic Urothelial CarcinomaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingBladder CancerUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdRecruitingUrinary Bladder NeoplasmsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedCarcinoma, Transitional Cell | Bladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Altor BioScienceNational Cancer Institute (NCI)CompletedTransitional Cell Carcinoma of Bladder | Urethra Cancer | Ureter Cancer | Malignant Tumor of Renal PelvisUnited States
-
Noah Hahn, M.D.Novartis Pharmaceuticals; Hoosier Cancer Research NetworkTerminatedBladder CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Clinical Stage III Cutaneous Melanoma AJCC v8 and other conditionsUnited States
-
Nottingham University Hospitals NHS TrustUniversity of Sydney; Australian and New Zealand Urogenital and Prostate Cancer...Active, not recruitingTransitional Cell Carcinoma | Transurethral ResectionUnited Kingdom
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnBladder Carcinoma | Post-operative PainUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Prokarium LtdRecruitingA Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1)NMIBC | Non Muscle Invasive Bladder Cancer | High Risk NMIBCUnited States
-
Mayo ClinicRecruitingMultiple Myeloma | Myelodysplastic Syndrome | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Hematopoietic and Lymphoid System Neoplasm | Advanced Lung Carcinoma | Advanced Prostate Carcinoma | Advanced Glioblastoma | Advanced Gastric Carcinoma | Advanced Breast Carcinoma | Advanced Colorectal... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterNew York University; Novartis Pharmaceuticals; University of HawaiiCompletedBladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Muscle Invasive Bladder Cancer (NMIBC)United States
-
The Methodist Hospital Research InstituteActive, not recruitingNon-Small Cell Lung Cancer | DNA Repair-Deficiency Disorders | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma Bladder | Classical Hodgkin Lymphoma | Malignant MelanomaUnited States
-
Institute of Cancer Research, United KingdomCompletedBladder CancerUnited Kingdom
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Musculoskeletal Transplant FoundationActive, not recruitingHernia | Bladder CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Endometrial Carcinoma | Stage III Bladder Cancer | Cervical Squamous Cell Carcinoma | Stage IV Breast Cancer | Malignant Uterine Neoplasm | Recurrent Bladder Carcinoma | Recurrent... and other conditionsUnited States
-
Mayo ClinicRecruiting
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineTerminated
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Transitional Cell Carcinoma of the Bladder | Localized Transitional Cell Cancer of the...United States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Locally Advanced Urothelial Carcinoma | Recurrent Urothelial Carcinoma | Unresectable Urothelial Carcinoma | Advanced Urothelial CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterTerminatedBladder Cancer | Urothelial CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruiting
-
SCRI Development Innovations, LLCCelgeneTerminatedTransitional Cell Carcinoma | Bladder Cancer | Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Stage IV Bladder Cancer AJCC v8 | Stage IV Renal Pelvis Cancer AJCC v8 | Stage IV Ureter Cancer... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); PfizerCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
CG Oncology, Inc.RecruitingBladder Cancer | Urothelial Carcinoma | Urologic Cancer | Non Muscle Invasive Bladder CancerUnited States
-
Matthew GalskyMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkCompletedBladder Cancer | Urothelial CarcinomaUnited States
-
Bristol-Myers SquibbCompletedTransitional Cell Carcinoma | Bladder Cancer | MetastasisUnited States, Korea, Republic of, United Kingdom, Spain, Australia, France, Thailand, Denmark, Poland, Belgium, Italy, Philippines, Canada, Russian Federation, Greece, Indonesia
-
SURGE TherapeuticsRecruitingNon-muscle-invasive Bladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRockefeller University; Pin Down Bladder Cancer Research FoundationRecruitingNon-muscle Invasive Bladder CancerUnited States
-
IO BiotechMerck Sharp & Dohme LLC; Theradex; Almac; NeoGenomicsRecruitingHead and Neck Squamous Cell Carcinoma | Urothelial Carcinoma Bladder | Lung Cancer Non Small CellUnited States, Spain, United Kingdom
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage III Bladder Cancer | No Evidence of Disease | Stage II Bladder Cancer | Stage IVA Bladder Cancer | Stage IVB Bladder CancerUnited States
-
University of California, DavisNational Institutes of Health (NIH); Lawrence Livermore National LaboratoryTerminatedCarcinoma, Non-Small-Cell Lung | Urinary Bladder NeoplasmsUnited States
-
ALX Oncology Inc.RecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Baylor College of MedicinePfizerTerminatedBladder Cancer | Invasive Bladder Cancer | Metastatic Bladder CancerUnited States
-
University of Texas Southwestern Medical CenterRecruitingSmoking Cessation | Bladder Cancer | Urothelial Carcinoma | HematuriaUnited States
-
Achieve Life SciencesPRA Health SciencesCompletedUrologic Neoplasms | Metastatic Bladder Cancer | Urinary Tract NeoplasmsSpain, United States, Canada, Italy, Poland, Germany, France
-
Jason R. BrownMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkActive, not recruitingBladder Cancer | Urothelial CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingProstate Cancer | Urothelial Carcinoma | Stage IV Bladder Urothelial CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterPfizerTerminatedBladder CancerUnited States
-
Early is Good Inc.RecruitingBladder CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedKidney Cancer | Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder CancerUnited States, Israel
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMelanoma | Soft Tissue Sarcoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Head and Neck Squamous Cell Carcinoma | Bladder Carcinoma | Colon Carcinoma | Pancreatic Carcinoma | Rectal Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Guardant Health, Inc.RecruitingRenal Cell Carcinoma | Pancreatic Adenocarcinoma | Gastric Adenocarcinoma | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung Cancer | Fallopian Tube Carcinoma | Endometrial Carcinoma | Bladder Carcinoma | Esophageal Carcinoma | Invasive Breast Carcinoma | Cutaneous Melanoma | Epithelial Ovarian... and other conditionsUnited States